Skip to main content

Research Report: Drug Delivery Systems Market Size Worth USD 71.75 Billion by 2029

According to Fortune Business Insights, Drug Delivery Systems Market to Hit USD 71.75 Billion by 2029, Gerresheimer AG and Midas Pharma’s Collaboration for New Generation Cartridge-based Auto Injector’s IP Purchase to Incite Development

Pune, India, Nov. 30, 2022 (GLOBE NEWSWIRE) — The global drug delivery systems market size is anticipated to hit USD 71.75 billion by 2029 and exhibit a CAGR of 9.0% during the forecast period. The rising prevalence of chronic diseases, coupled with the increasing patients’ inclination towards advanced drug delivery systems are projected to fuel the market’s growth. Fortune Business InsightsTM has presented this information in its research report titled, “Drug Delivery Systems Market, 2022-2029”. The market size stood at USD 34.70 billion in 2021 and USD 39.33 billion in 2022.

Additionally, the new product launches and strategic collaborations by major players operating in the market are expected to be a key trend stimulating the market’s growth.  


Get Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-delivery-systems-market-103070


Industry Developments-

  • November 2021: Gerresheimer AG and Midas Pharma collaborated to buy the Intellectual Property (IP) of a next-generation cartridge-based auto-injector.

Drivers & Restraints-

Rising Prevalence of Chronic Diseases to Propel Market Growth

The growing prevalence of chronic diseases, including diabetes, cancer, Chronic Obstructive Pulmonary Disease (COPD), asthma, and others, and the subsequent fatalities due to these chronic diseases are expected to be a major factor promoting the growth of the drug delivery systems market. The globally expanding geriatric populace and their susceptibility to fatal diseases are likely to surge the demand for advanced drug delivery systems and foster market growth.
The increasing shift of patients towards modern products and advanced drug delivery systems due to their improved efficacy and accuracy is anticipated to amplify the market’s growth in the coming years.
Lastly, the new product launches and strategic collaborations by major market players are expected to magnify the market’s growth in the coming years.
However, strict regulations and frequent product recalls are predicted to hamper the market’s growth during the forecast period.


For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-delivery-systems-market-103070



Competitive Landscape-

Key Players Embrace Strategic Collaborations to Garner Growth

The highly consolidated marketplace embraces the presence of major market players including West Pharmaceutical Services Inc., Baxter International Inc., BD, and Gerresheimer AG. The major players operating in the market emphasize new product launches, strategic collaborations, and others to amplify their revenues and market presence. For instance, Nemera acquired Copernicus in October 2020 to expand its proprietary product portfolio.

COVID-19 Impact-

The coronavirus pandemic has potentially caused an uptick in the global drug delivery systems market growth. The accelerated manufacturing of injectable drug delivery systems has substantially fuelled the market’s growth. The soaring number of vaccinations being administered globally is bolstering the market’s growth. Moreover, the growing use of self-injection devices and easy-to-use homecare solutions is boosting the demand for advanced drug delivery systems, thereby fostering growth for the market.

Segmentation-

On the basis of type, the market is fragmented into injectable, transdermal, inhalation, and others. On the basis of device type, the market is bifurcated into advanced and conventional. On the basis of distribution channels, the market is segmented into retail pharmacies, hospital pharmacies, and others. Geographically, the market is classified into Latin America, the Middle East & Africa, Europe, Asia Pacific, and North America.


Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/103070


Report Coverage-

  • It covers information on different market segments.
  • It includes an assessment of the COVID-19 pandemic’s impact on the market.
  • It incorporates Porters’ Five Forces Analysis for precise market prediction.
  • It addresses the latest developments witnessed in the market.
  • It highlights the various restraints and drivers of the market’s growth.

North America to Attain Dominance Due to Increasing Product Demand

North America is predicted to attain the dominant drug delivery systems market share during the forecast period. The exponential increase in syringes’ demand due to escalating COVID-19 vaccinations is aiding the market’s expansion. Moreover, the high number of hospitalizations has created an escalated demand for advanced drug delivery systems, which is magnifying the region’s market expansion.
Europe is projected to gain immense growth in the upcoming years. The rising adoption of advanced products, coupled with the increasing consumer awareness for advanced drug delivery systems propels growth in Europe.
Asia Pacific is expected to witness swift expansion due to a vast patient pool and growing chronic disease prevalence. Moreover, production capacity expansions by major players to fulfill the ever-growing demand are anticipated to aid market’s growth in Asia Pacific.


Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/customization/drug-delivery-systems-market-103070


List of Key Market Players-

  • Gerresheimer AG (Germany)
  • BD (Becton, Dickinson, and Company) (U.S.)
  • Kindeva Drug Delivery (U.S.)
  • Baxter (U.S.)
  • West Pharmaceutical Services Inc. (U.S.)
  • Ypsomed (Switzerland)
  • Medtronic (Ireland)
  • Nemara (France)
  • E3D Elca, Drug Delivery Devices (Israel)

Table of Contents

  • Introduction
    • Market Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • New Product Launches
    • Technological Advancements in the Drug Device Systems Market
    • Key Industry Developments – Mergers, Acquisitions, and Partnerships
    • Impact of Drug Delivery Systems on Stakeholders
    • Key Market Trends
    • Impact of COVID-19 on the Market
  • Global Drug Delivery Systems Market Analysis, Insights and Forecast, 2018-2029
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Inhalation
      •  Transdermal
      •  Injectable
      •  Others
    • Market Analysis, Insights and Forecast – By Device Type
      •  Conventional
      •  Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •  Hospitals Pharmacies
      •  Retail Pharmacies
      •  Others
    • Market Analysis, Insights and Forecast – By Region
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa
  • North America Drug Delivery Systems Market Analysis, Insights and Forecast, 2018-2029
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Inhalation
      •  Transdermal
      •  Injectable
      •  Others
    • Market Analysis, Insights and Forecast – By Device Type
      •  Conventional
      •  Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •  Hospitals Pharmacies
      •  Retail Pharmacies
      •  Others
    • Market Analysis, Insights and Forecast – By Country
      •  U.S.
      •  Canada
  • Europe Drug Delivery Systems Market Analysis, Insights and Forecast, 2018-2029
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Inhalation
      •  Transdermal
      •  Injectable
      •  Others
    • Market Analysis, Insights and Forecast – By Device Type
      •  Conventional
      •  Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •  Hospitals Pharmacies
      •  Retail Pharmacies
      •  Others
    • Market Analysis, Insights and Forecast – By Country/ Sub-region
      •  Germany
      •  U.K.
      •  France
      •  Italy
      •  Spain
      •  Scandinavia
      •  Rest of Europe

TOC Continued…….


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/drug-delivery-systems-market-103070


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:

U.S.:+1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/drug-delivery-systems-market-10044

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.